Cellegy Pharmaceuticals Inc. (CLGY/CLGY.OB) Wrap Up:

Cellegy Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company. The company, through its subsidiary, Biosyn, Inc., owns intellectual property relating to a portfolio of proprietary product candidates known as microbicides. It engages in the development and commercialization of prescription drugs, which include contraceptive and non-contraceptive microbicides used intravaginally and are intended to reduce transmission of sexually transmitted diseases, such as human immunodeficiency virus, acquired immunodeficiency disease, female sexual dysfunction, and gastrointestinal conditions primarily for women’s health care market. The company’s principal product candidates include Sav...